Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T17:47:32.926Z.
Consensus retrieved: unavailable. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T17:47:32.926Z.
Quote observation: 2026-10-06T17:43:29.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 99ee00bc2f4aa40d5d918347778efcb7f19b116313d5be84bba1ddfc51e138d0
FORWARD PE RATIO
N/A
Nortech Systems Incorporated
Market Cap
$31.47M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Nortech Systems Incorporated (NSYS) | $31.47M | N/A |
| Rockwell Medical, Inc. (RMTI)vs › | $31.97M | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $30.85M | 9.14 |
| SCYNEXIS, Inc. (SCYX)vs › | $30.56M | N/A |
| MDxHealth S.A. (MDXH)vs › | $30.51M | N/A |
| Scilex Holding Company (SCLX)vs › | $32.52M | N/A |
| BeyondSpring Inc. (BYSI)vs › | $30.06M | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $32.92M | N/A |
| CervoMed Inc. (CRVO)vs › | $29.91M | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $29.86M | N/A |
Trailing P/E
30.6
reported TTM EPS
Forward P/E
N/A
consensus fiscal-year EPS
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
